Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-08-0110
European Journal of Endocrinology, Vol 159, Issue 3, 329-341
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0110v1
159/3/329    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haentjens, P.
Right arrow Articles by Velkeniers, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haentjens, P.
Right arrow Articles by Velkeniers, B.

CLINICAL STUDIES

Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies

Patrick Haentjens1,2, Alain Van Meerhaeghe3, Kris Poppe4,5 and Brigitte Velkeniers4,5

1 Center for Outcomes Research and Laboratory for Experimental SurgeryUniversitair Ziekenhuis Brussel and Vrije Universiteit Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium2 CEBAMCentre for Evidence Based Medicine, Belgian Branch of the Cochrane Collaboration, B-3000 Leuven, Belgium3 Service de Pneumologie ISPPC CHU A. VésaleMontigny-le-Tilleul, Belgium4 Department of Endocrinology5 Department of General Internal MedicineUniversitair Ziekenhuis Brussel, Vrije Universiteit Brussel, B-1090 Brussels, Belgium

(Correspondence should be addressed to P Haentjens; Email: patrick.haentjens{at}uzbrussel.be)

Objectives: To what extent persons with subclinical hyper- or hypothyroidism are more (or less) likely to die than euthyroid control subjects remains a matter of controversy.

Methods: We searched electronic reference databases up to July 31, 2007. Three reviewers independently assessed eligibility. Cohort studies published in full that reported data on the hazard ratio (HR) for mortality from all causes in persons with subclinical thyroid dysfunction versus euthyroid controls were included.

Results: Based on seven cohorts including 290 participants with subclinical hyperthyroidism, random-effects models estimated that the pooled HR for all-cause mortality was 1.41 (95% confidence interval (CI), 1.12–1.79; P=0.004). Using the pooled HR and standard life-table methods applied to a US reference population, we estimated that a white US woman, when diagnosed with subclinical hyperthyroidism at age of 70, has an excess mortality of 1.5, 4.0, and 8.7% at 2, 5, and 10 years respectively after diagnosis. Likewise, a white US man has an excess mortality of 2.3, 5.7, and 10.7%. For the nine cohorts including 1580 participants with subclinical hypothyroidism, observed heterogeneity (Q test P=0.006; I2=63%) disappeared after pooling cohorts in predefined subgroups according to the presence or absence of a comorbid condition. In doing so, the pooled HR for all-cause mortality was 1.03 (95% CI, 0.78–1.35; P=0.83) in cohorts from the community and 1.76 (95% CI, 1.36–2.30; P<0.001) in cohorts of participants with comorbidities (P=0.014 for heterogeneity among study groups).

Conclusions: Individuals with subclinical hyperthyroidism demonstrate a 41% increase in relative mortality from all causes versus euthyroid control subjects. Mathematical modeling suggests that absolute excess mortality after diagnosis might depend on age, with an increase beyond the age of 60, especially in aging men. For patients with subclinical hypothyroidism, the relative risk of all-cause mortality is increased only in patients with comorbid conditions.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. A Sgarbi, L. K Matsumura, T. S Kasamatsu, S. R Ferreira, and R. M B Maciel
Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study
Eur. J. Endocrinol., March 1, 2010; 162(3): 569 - 577.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
F. A Ashkar, P. M Bartlewski, J. Singh, P. S Malhi, K. M Yates, T. Singh, and W A. King
Thyroid hormone concentrations in systemic circulation and ovarian follicular fluid of cows
Exp Biol Med, February 1, 2010; 235(2): 215 - 221.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Klubo-Gwiezdzinska and L. Wartofsky
Thyrotropin Blood Levels, Subclinical Hypothyroidism, and the Elderly Patient
Arch Intern Med, November 23, 2009; 169(21): 1949 - 1951.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E Forestier, S Vinzio, R Sapin, J L Schlienger, and B Goichot
Increased reverse triiodothyronine is associated with shorter survival in independently-living elderly: the Alsanut study
Eur. J. Endocrinol., February 1, 2009; 160(2): 207 - 214.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
V. Fatourechi
Subclinical Hypothyroidism: An Update for Primary Care Physicians
Mayo Clin. Proc., January 1, 2009; 84(1): 65 - 71.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 European Society of Endocrinology.